查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504217

生物标记的市场规模，占有率，预测，趋势分析:机制，各技术，各用途，各疾病，各终端用户-2031年前的全球预测

Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type Mechanism Technology, Offering, Application, Disease Type, End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 350 Pages | 商品交期: 5-7个工作天内

价格

生物标记物市场预计到 2031 年将达到 2013.3 亿美元，2024 年至 2031 年复合年增长率为 14.3%

经过广泛的二次和初步研究以及对生物标记物市场情景的详细分析，本报告包括对关键行业驱动因素、限制因素和市场驱动因素/课题的分析。这一市场成长的推动因素包括药物研究支出的增加、目标疾病盛行率的上升、生物标记检测的技术进步、对临床研究的日益关注、生物标记研究资金的增加，这被认为是由于多种因素造成的，包括关注度的增加早期诊断和生物标记的多方面应用。然而，生物标誌物发现的高资本投资和生物标誌物开发的漫长时间限制了市场的成长。

此外，对伴随诊断的更多关注、对生物标记的持续研究以及向精准肿瘤学的转变预计将提供成长机会。然而，与生物标记验证相关的课题以及样本收集和储存的技术问题是市场成长的主要课题。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第 4 章市场洞察

  • 摘要
  • 促进因素
    • 药物研究费用增加
    • 目标疾病的盛行率不断上升
    • 生物标记检测技术的进步
    • 日益关注临床研究
    • 增加生物标记研究资金
    • 越来越重视疾病的早期诊断
    • 生物标记的多种应用
  • 抑制因素
    • 生物标记发现的高资本投资
    • 生物标记物开发的时间较长
  • 机会
    • 增加研发经费
    • 越来越重视伴随诊断
    • 正在进行的生物标记研究
    • 转向精准肿瘤学
  • 作业
    • 与生物标记验证相关的问题
    • 有关样本采集和储存的技术问题
  • 因素分析
  • 趋势
  • 监理分析
  • 波特五力分析

第 5 章生物标记市场：依生物标记类型进行评估

  • 摘要
  • 功效生物标记
    • 预后生物标记
    • 药效生物标记
    • 替代生物标记
    • 预测性生物标记
  • 验证生物标记
  • 安全生物标记

第 6 章生物标记市场：依产品评估

  • 摘要
  • 消耗品
    • 检测试剂盒
    • 试剂
    • 其他消耗品
  • 服务与软体

第 7 章生物标记市场：基于机制的评估

  • 摘要
  • 基因生物标记
  • 表观遗传生物标记
  • 蛋白质体学生物标誌物
  • 脂质组学生物标誌物
  • 其他机制

第 8 章生物标记市场：透过分析技术进行评估

  • 摘要
  • 免疫分析
    • ELISA法
    • 蛋白质印迹
    • 蛋白质微阵列
  • NGS
  • PCR
  • 质谱分析
  • 色谱法
  • 其他技术

第9章 生物标记市场:各疾病类型评估

  • 概要
  • 肿瘤学
  • 心血管疾病
  • 感染疾病
  • 神经疾病
  • 糖尿病以及其他的代谢性疾病
  • 其他的疾病

第10章 生物标记市场:各用途评估

  • 概要
  • 诊断
  • 药物研发和医药品开发
  • 个人化医疗
  • 临床研究
  • 其他的用途

第11章 生物标记市场:各终端用户评估

  • 概要
  • 製药·生物科技企业
  • 医院
  • 诊断研究所
  • 其他的终端用户

第12章 生物标记市场:各地区评估

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 瑞士
    • 比利时
    • 荷兰
    • 其他欧洲(RoE)
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 其他亚太地区(RoAPAC)
  • 南美
  • 中东·非洲

第13章 竞争分析

  • 概要
  • 主要成长策略
  • 竞争基准
  • 竞争仪表板
    • 产业领导者
    • 市场差异化要素
    • 领先企业
    • 新兴企业
  • 各主要企业市场占有率分析/市场排行榜(2023年)

第14章 企业简介(企业概要，财务概要，产品系列，策略性展开)

  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Epigenomics AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • Bio-Rad Laboratories
  • Revvity Inc.
  • Siemens Healthineers AG
  • Mindray
  • Eurofins Scientific SE
  • bioMerieux SA
  • Agilent Technologies, Inc.
  • Quanterix Corp.
  • Thermo Fisher Scientific Inc.

(註：提供前 5 名公司 SWOT 分析)

第15章 附录

Product Code: MRHC - 1041186

Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Efficacy, Validation, Safety) Mechanism (Genetic, Epigenetic, Proteomic) Technology (ELISA, Microarray, PCR, NGS), Offering, Application, Disease Type, End User - Global Forecast to 2031

The Biomarkers Market is Projected to Reach $201.33 Billion by 2031 at a CAGR of 14.3% from 2024 to 2031

Succeeding extensive secondary and primary research and in-depth analysis of the biomarkers market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market can be attributed to various factors, such as the increasing pharmaceutical research spending, rising prevalence of target diseases, technological advancements in biomarker detection, rising focus on clinical research, increasing funding for biomarker research, rising focus on early disease diagnosis, and application of biomarkers in multiple areas. However, high capital investment for biomarker discovery and a lengthy timeline for biomarker development restrain the market's growth.

Furthermore, a rising focus on companion diagnostics, ongoing research on biomarkers, and a shift toward precision oncology are expected to offer growth opportunities. However, the challenges associated with biomarker validation and technical issues related to sample collection and storage are major challenges for the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the global biomarkers market are F. Hoffmann-La Roche AG (Switzerland), Merck KGaA (Germany), Epigenomics AG (Germany), Abbott Laboratories (U.S.), QIAGEN N.V. (Germany), Bio-Rad Laboratories (U.S.), Revvity Inc (U.S.), Siemens Healthineers AG (Germany), Mindray (China), Thermo Fisher Scientific Inc. (U.S.), Eurofins Scientific SE (France), bioMerieux SA (France), Agilent Technologies, Inc. (U.S.), and Quanterix Corp. (U.S.).

Among all the biomarker types studied in this report, in 2024, the safety biomarkers segment is expected to account for the largest share of 42.4% of the biomarkers market. Safety biomarkers are used to assess the safety or potential risks after and before exposure to a medical product or environmental agent. The large share of the segment is attributed to the increase in drug discovery research and availability of funding. The large number of drugs entering clinical trials every year is contributing to the large share of the segment. Further, the rising number of drug recalls by regulatory agencies over toxicity concerns is increasing the adoption of safety biomarkers to assess toxicity.

Among all the offerings studied in this report, in 2024, the consumables segment is expected to account for the largest share of the biomarkers market. High adoption and recurring consumption of biomarker identification and testing kits, and wide availability of consumables support the largest share of the market. Additionally, the increasing adoption of these kits by researchers during drug discovery and clinical trials to assess the toxicity is contributing to the large share of the segment.

Among all the mechanisms studied in this report, in 2024, the epigenetic biomarkers segment is expected to account for the largest share of the biomarkers market. The rise in the prevalence of infectious and non-infectious diseases, coupled with the rising need to bring novel therapies to the market, is generating demand for epigenetic biomarkers. Additionally, epigenetic biomarkers are used in a range of applications, such as disease diagnosis and prognosis, treatment response prediction, and personalized medicines.

Among all the profiling technologies studied in this report, in 2024, the immunoassay segment is expected to account for the largest share of the biomarkers market. The large share of the segment is attributed to the high sensitivity and specificity of immunoassay, relatively lower cost, high flexibility & accessibility, and technological advancements. Additionally, the wide utilization of immunoassays in clinical diagnostics, drug discovery, and drug monitoring for biomarker detection contributes to the largest share of the market.

Among all the disease types studied in this report, in 2024, the oncology segment is expected to account for the largest share of the biomarkers market. In cancer research, biomarkers are used for wide applications such as early detection, diagnosis, prognosis, and treatment. The rising prevalence of cancer, increasing funding for oncology biomarker research, and increasing focus on precision oncology are the factors supporting the large share of the segment.

Among all the applications studied in this report, in 2024, the drug discovery & development segment is expected to account for the largest share of the biomarkers market. The rise in the number of molecules in clinical trials, the growing focus on cancer research, and the high spending and availability of funding for cancer research are supporting the segment's large share. The increasing spending and funding for drug discovery & development are further contributing to the largest share of the segment. For instance, In June 2023, the Commonwealth Government's Medical Research Future Fund (MRFF) (Australia) invested USD 9.75 million in establishing MedChem Australia, a new national medicinal chemistry initiative, to accelerate the identification of early-stage drug candidates.

Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the biomarkers market. Pharmaceutical & biotechnology companies use biomarkers in drug discovery & development to enhance efficacy and safety. The largest share of the segment is attributed to high spending on R&D by pharmaceutical companies, a focus on developing novel therapies, and a growing focus on personalized medicines.

An in-depth analysis of the geographical scenario of the global biomarkers market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of 49.2% of the biomarkers market. The largest share of the region is attributed to the presence of key players, substantial R&D investments by pharmaceutical and biotechnology companies for drug and biomarker development, and supportive government initiatives. The regional government is focusing on biomarker research, further supporting the largest share in the region. For instance, in June 2024, The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) launched a project, MMyeRisk, a project to evaluate tumor and immune biomarkers to predict progression from early precursor conditions to multiple myeloma and identify patients likely to benefit from earlier treatment.

Scope of the Report:

Biomarkers Market Assessment-by Biomarker Type

  • Efficacy Biomarkers
    • Prognostic Biomarkers
    • Pharmacodynamic Biomarkers
    • Surrogate Biomarkers
    • Predictive Biomarkers
  • Validation Biomarkers
  • Safety Biomarkers

Biomarkers Market Assessment-by Offering

  • Consumables
    • Assay Kits
    • Reagents
    • Other Consumables
  • Services & Software

Note: Other consumables include columns, filters, and microplates

Biomarkers Market Assessment-by Mechanism

  • Genetic Biomarkers
  • Epigenetic Biomarkers
  • Proteomic Biomarkers
  • Lipidomic Biomarkers
  • Other Mechanisms

Note: Other mechanisms include metabolic biomarkers and inflammatory biomarkers

Biomarkers Market Assessment-by Profiling Technology

  • Immunoassay
    • ELISA
    • Western Blot
    • Protein Microarray
  • NGS
  • PCR
  • Mass Spectrometry
  • Chromatography
  • Other Technologies

Note: Other technologies include flow cytometry, electrophoresis, and DNA microarray

Biomarkers Market Assessment-by Disease Type

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurological Disorders
  • Diabetes And Other Metabolic Diseases
  • Other Diseases

Note: Note: Other diseases include autoimmune diseases, blood disorders, and CNS diseases

Biomarkers Market Assessment-by Application

  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Clinical Research
  • Other Applications

Note: Other applications include prognosis, risk assessment, and forensic

Biomarkers Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users

Note: Other end users include academic & research institutes and forensics

Biomarkers Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Switzerland
    • Belgium
    • Netherlands
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Pharmaceutical Research Spending
    • 4.2.2. Rising Prevalence of Target Diseases
    • 4.2.3. Technological Advancements in Biomarker Detection
    • 4.2.4. Rising Focus on Clinical Research
    • 4.2.5. Increasing Funding for Biomarker Research
    • 4.2.6. Rising Focus on Early Disease Diagnosis
    • 4.2.7. Applications of Biomarkers in Multiple Areas
  • 4.3. Restraints
    • 4.3.1. High Capital Investment for Biomarker Discovery
    • 4.3.2. Lengthy Timeline for Biomarker Development
  • 4.4. Opportunities
    • 4.4.1. Rising Funding for R&D
    • 4.4.2 Rising Focus on Companion Diagnostics
    • 4.4.3. Ongoing Research on Biomarkers
    • 4.4.4. Shift Towards Precision Oncology
  • 4.5. Challenges
    • 4.5.1. Challenges Associated with Biomarkers Validation
    • 4.5.2. Technical Issues Related to Sample Collection and Storage
  • 4.6. Factor Analysis
  • 4.7. Trends
  • 4.8. Regulatory Analysis
  • 4.9. Porter's Five Force Analysis

5. Biomarkers Market Assessment-by Biomarker Type

  • 5.1. Overview
  • 5.2. Efficacy Biomarkers
    • 5.2.1. Prognostic Biomarkers
    • 5.2.2. Pharmacodynamic Biomarkers
    • 5.2.3. Surrogate Biomarkers
    • 5.2.4. Predictive Biomarkers
  • 5.3. Validation Biomarkers
  • 5.4. Safety Biomarkers

6. Biomarkers Market Assessment-by Offerings

  • 6.1. Overview
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Reagents
    • 6.2.3. Other Consumables
  • 6.3. Services & Software

7. Biomarkers Market Assessment-by Mechanism

  • 7.1. Overview
  • 7.2. Genetic Biomarkers
  • 7.3. Epigenetic Biomarkers
  • 7.4. Proteomic Biomarkers
  • 7.5. Lipidomic Biomarkers
  • 7.6. Other Mechanisms

8. Biomarkers Market Assessment-by Profiling Technology

  • 8.1. Overview
  • 8.2. Immunoassay
    • 8.2.1. ELISA
    • 8.2.2. Western Blot
    • 8.2.3. Protein Microarray
  • 8.3. NGS
  • 8.4. PCR
  • 8.5. Mass Spectrometry
  • 8.6. Chromatography
  • 8.7. Other Technologies

9. Biomarkers Market Assessment-by Disease Type

  • 9.1. Overview
  • 9.2. Oncology
  • 9.3. Cardiovascular Diseases
  • 9.4. Infectious Diseases
  • 9.5. Neurological Disorders
  • 9.6. Diabetes and Other Metabolic Diseases
  • 9.7. Other Diseases

10. Biomarkers Market Assessment-by Application

  • 10.1. Overview
  • 10.2. Diagnostics
  • 10.3. Drug Discovery and Development
  • 10.4. Personalized Medicine
  • 10.5. Clinical Research
  • 10.6. Other Applications

11. Biomarkers Market Assessment-by End User

  • 11.1. Overview
  • 11.2. Pharmaceutical & Biotechnology Companies
  • 11.3. Hospitals
  • 11.4. Diagnostic Laboratories
  • 11.5. Other End Users

12. Biomarkers Market Assessment-by Geography

  • 12.1. Overview
  • 12.2. North America
    • 12.2.1. U.S.
    • 12.2.2. Canada
  • 12.3. Europe
    • 12.3.1. Germany
    • 12.3.2. France
    • 12.3.3. U.K.
    • 12.3.4. Italy
    • 12.3.5. Spain
    • 12.3.6. Switzerland
    • 12.3.7. Belgium
    • 12.3.8. Netherlands
    • 12.3.9. Rest of Europe (RoE)
  • 12.4. Asia-Pacific
    • 12.4.1. Japan
    • 12.4.2. China
    • 12.4.3. India
    • 12.4.4. South Korea
    • 12.4.5. Rest of Asia-Pacific (RoAPAC)
  • 12.5. Latin America
  • 12.6. Middle East & Africa

13. Competition Analysis

  • 13.1. Overview
  • 13.2. Key Growth Strategies
  • 13.3. Competitive Benchmarking
  • 13.4. Competitive Dashboard
    • 13.4.1. Industry Leaders
    • 13.4.2. Market Differentiators
    • 13.4.3. Vanguards
    • 13.4.4. Emerging Companies
  • 13.5. Market Share Analysis/Market Ranking, by Key Players (2023)

14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 14.1. F. Hoffmann-La Roche AG
  • 14.2. Merck KGaA
  • 14.3. Epigenomics AG
  • 14.4. Abbott Laboratories
  • 14.5. QIAGEN N.V.
  • 14.6. Bio-Rad Laboratories
  • 14.7. Revvity Inc.
  • 14.8. Siemens Healthineers AG
  • 14.9. Mindray
  • 14.10. Eurofins Scientific SE
  • 14.11. bioMerieux SA
  • 14.12. Agilent Technologies, Inc.
  • 14.13. Quanterix Corp.
  • 14.14. Thermo Fisher Scientific Inc.

(Note: SWOT analysis of the top 5 companies will be provided.)

15. Appendix

  • 15.1. Available Customization
  • 15.2. Related Reports

LIST OF TABLES

  • Table 1 Global Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 2 Global Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 3 Global Efficacy Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Prognostic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Pharmacodynamic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Surrogate Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Predictive Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Validation Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Safety Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Biomarkers Market, by Offerings, 2022-2031 (USD Million)
  • Table 11 Global Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 12 Global Biomarkers Market for Consumables, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Biomarkers Market for Assay Kits, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Biomarkers Market for Reagents, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Biomarkers Market for Other Consumables, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Biomarkers Market for Services & Software, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 18 Global Genetic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Epigenetic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Proteomic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Lipidomic Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Biomarkers Market for Other Mechanisms, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 24 Global Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 25 Global Biomarkers Market for Immunoassay, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Global Biomarkers Market for ELISA, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Biomarkers Market for Western Blot, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Biomarkers Market for Protein Microarray, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Biomarkers Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Biomarkers Market for PCR, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Biomarkers Market for Mass Spectrometry, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Biomarkers Market for Chromatography, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Biomarkers Market for Other Technologies, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 35 Global Biomarkers Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Biomarkers Market for Cardiovascular Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Biomarkers Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Biomarkers Market for Neurological Disorders, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Biomarkers Market for Diabetes and Other Metabolic Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Biomarkers Market for Other Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 42 Global Biomarkers Market for Diagnostics, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global Biomarkers Market for Drug Discovery and Development, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global Biomarkers Market for Personalized Medicine, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Biomarkers Market for Clinical Research, by Country/Region, 2022-2031 (USD Million)
  • Table 46 Global Biomarkers Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 47 Global Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 48 Global Biomarkers Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global Biomarkers Market for Hospitals, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Global Biomarkers Market for Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 51 Global Biomarkers Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Global Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 53 North America: Biomarkers Market, by Country, 2022-2031 (USD Million)
  • Table 54 North America: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 55 North America: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 56 North America: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 57 North America: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 58 North America: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 59 North America: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 60 North America: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 61 North America: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 62 North America: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 63 North America: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 64 U.S.: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 65 U.S.: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 66 U.S.: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 67 U.S.: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 68 U.S.: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 69 U.S.: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 70 U.S.: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 71 U.S.: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 72 U.S.: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 73 U.S.: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 74 Canada: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 75 Canada: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 76 Canada: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 77 Canada: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 78 Canada: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 79 Canada: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 80 Canada: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 81 Canada: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 82 Canada: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 83 Canada: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 84 Europe: Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 85 Europe: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 86 Europe: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 87 Europe: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 88 Europe: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 89 Europe: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 90 Europe: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 91 Europe: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 92 Europe: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 93 Europe: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 94 Europe: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 95 Germany: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 96 Germany: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 97 Germany: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 98 Germany: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 99 Germany: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 100 Germany: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 101 Germany: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 102 Germany: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 103 Germany: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 104 Germany: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 105 France: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 106 France: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 107 France: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 108 France: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 109 France: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 110 France: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 111 France: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 112 France: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 113 France: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 114 France: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 115 U.K.: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 116 U.K.: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 117 U.K.: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 118 U.K.: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 119 U.K.: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 120 U.K.: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 121 U.K.: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 122 U.K.: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 123 U.K.: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 124 U.K.: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 125 Italy: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 126 Italy: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 127 Italy: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 128 Italy: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 129 Italy: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 130 Italy: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 131 Italy: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 132 Italy: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 133 Italy: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 134 Italy: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 135 Spain: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 136 Spain: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 137 Spain: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 138 Spain: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 139 Spain: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 140 Spain: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 141 Spain: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 142 Spain: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 143 Spain: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 144 Spain: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 145 Switzerland: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 146 Switzerland: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 147 Switzerland: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 148 Switzerland: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 149 Switzerland: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 150 Switzerland: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 151 Switzerland: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 152 Switzerland: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 153 Switzerland: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 154 Switzerland: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 155 Belgium: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 156 Belgium: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 157 Belgium: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 158 Belgium: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 159 Belgium: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 160 Belgium: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 161 Belgium: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 162 Belgium: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 163 Belgium: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 164 Belgium: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 165 Netherlands: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 166 Netherlands: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 167 Netherlands: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 168 Netherlands: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 169 Netherlands: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 170 Netherlands: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 171 Netherlands: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 172 Netherlands: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 173 Netherlands: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 174 Netherlands: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 175 Rest of Europe: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 176 Rest of Europe: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 177 Rest of Europe: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 178 Rest of Europe: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 179 Rest of Europe: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 180 Rest of Europe: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 181 Rest of Europe: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 182 Rest of Europe: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 183 Rest of Europe: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 184 Rest of Europe: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 185 Asia-Pacific: Biomarkers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 186 Asia-Pacific: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 187 Asia-Pacific: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 188 Asia-Pacific: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 189 Asia-Pacific: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 190 Asia-Pacific: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 191 Asia-Pacific: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 192 Asia-Pacific: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 193 Asia-Pacific: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 194 Asia-Pacific: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 195 Asia-Pacific: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 196 China: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 197 China: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 198 China: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 199 China: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 200 China: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 201 China: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 202 China: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 203 China: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 204 China: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 205 China: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 206 Japan: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 207 Japan: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 208 Japan: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 209 Japan: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 210 Japan: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 211 Japan: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 212 Japan: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 213 Japan: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 214 Japan: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 215 Japan: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 216 India: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 217 India: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 218 India: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 219 India: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 220 India: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 221 India: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 222 India: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 223 India: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 224 India: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 225 India: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 226 South Korea: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 227 South Korea: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 228 South Korea: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 229 South Korea: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 230 South Korea: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 231 South Korea: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 232 South Korea: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 233 South Korea: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 234 South Korea: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 235 South Korea: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 236 Rest of Asia-Pacific: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 237 Rest of Asia-Pacific: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 238 Rest of Asia-Pacific: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 239 Rest of Asia-Pacific: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 240 Rest of Asia-Pacific: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 241 Rest of Asia-Pacific: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 242 Rest of Asia-Pacific: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 243 Rest of Asia-Pacific: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 244 Rest of Asia-Pacific: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 245 Rest of Asia-Pacific: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 246 Latin America: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 247 Latin America: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 248 Latin America: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 249 Latin America: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 250 Latin America: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 251 Latin America: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 252 Latin America: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 253 Latin America: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 254 Latin America: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 255 Latin America: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 256 Middle East & Africa: Biomarkers Market, by Biomarker Type, 2022-2031 (USD Million)
  • Table 257 Middle East & Africa: Efficacy Biomarkers Market, by Type, 2022-2031 (USD Million)
  • Table 258 Middle East & Africa: Biomarkers Market, by Offering, 2022-2031 (USD Million)
  • Table 259 Middle East & Africa: Biomarkers Market for Consumables, by Type, 2022-2031 (USD Million)
  • Table 260 Middle East & Africa: Biomarkers Market, by Mechanism, 2022-2031 (USD Million)
  • Table 261 Middle East & Africa: Biomarkers Market, by Profiling Technology, 2022-2031 (USD Million)
  • Table 262 Middle East & Africa: Biomarkers Market for Immunoassay, by Type, 2022-2031 (USD Million)
  • Table 263 Middle East & Africa: Biomarkers Market, by Disease Type, 2022-2031 (USD Million)
  • Table 264 Middle East & Africa: Biomarkers Market, by Application, 2022-2031 (USD Million)
  • Table 265 Middle East & Africa: Biomarkers Market, by End User, 2022-2031 (USD Million)
  • Table 266 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Biomarkers Market, by Biomarker Type, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Biomarkers Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Biomarkers Market, by Mechanism, 2024 VS. 2031 (USD Million)
  • Figure 10 Global Biomarkers Market, by Profiling Technology, 2024 VS. 2031 (USD Million)
  • Figure 11 Global Biomarkers Market, by Disease Type, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Biomarkers Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 13 Global Biomarkers Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Biomarkers Market, by Geography
  • Figure 15 Global Biomarkers Market, by Biomarker Type, 2024 VS. 2031 (USD Million)
  • Figure 16 Global Biomarkers Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 17 Global Biomarkers Market, by Mechanism, 2024 VS. 2031 (USD Million)
  • Figure 18 Global Biomarkers Market, by Profiling Technology, 2024 VS. 2031 (USD Million)
  • Figure 19 Global Biomarkers Market, by Disease Type, 2024 VS. 2031 (USD Million)
  • Figure 20 Global Biomarkers Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 21 Global Biomarkers Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 22 Global Biomarkers Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 23 North America: Biomarkers Market Snapshot
  • Figure 24 Europe: Biomarkers Market Snapshot
  • Figure 25 Asia-Pacific: Biomarkers Market Snapshot
  • Figure 26 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 27 Global Biomarkers Market: Competitive Benchmarking, by Offerings
  • Figure 28 Global Biomarkers Market: Competitive Benchmarking, by Geography
  • Figure 29 Global Biomarkers Market: Competitive Dashboard
  • Figure 30 Global Biomarkers Market: Market Share Analysis/Market Ranking (2023)
  • Figure 31 F. Hoffmann-La Roche AG: Financial Snapshot (2023)
  • Figure 32 Merck KGaA: Financial Snapshot (2023)
  • Figure 33 Epigenomics AG: Financial Snapshot (2023)
  • Figure 34 Abbott Laboratories: Financial Snapshot (2023)
  • Figure 35 QIAGEN N.V.: Financial Snapshot (2023)
  • Figure 36 Bio-Rad Laboratories: Financial Snapshot (2023)
  • Figure 37 Revvity Inc.: Financial Snapshot (2023)
  • Figure 38 Siemens Healthineers AG: Financial Snapshot (2023)
  • Figure 39 Mindray: Financial Snapshot (2023)
  • Figure 40 Eurofins Scientific SE: Financial Snapshot (2023)
  • Figure 41 bioMerieux SA: Financial Snapshot (2023)
  • Figure 42 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 43 Quanterix Corp.: Financial Snapshot (2023)
  • Figure 44 Thermo Fisher Scientific Inc: Financial Snapshot (2023)

Download Free Sample Report